Haemonetics Total Assets 2010-2025 | HAE

Haemonetics total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
Haemonetics Annual Total Assets
(Millions of US $)
2025 $2,451
2024 $2,196
2023 $1,935
2022 $1,860
2021 $1,820
2020 $1,267
2019 $1,275
2018 $1,237
2017 $1,239
2016 $1,319
2015 $1,485
2014 $1,514
2013 $1,462
2012 $911
2011 $833
2010 $761
2009 $650
Haemonetics Quarterly Total Assets
(Millions of US $)
2025-03-31 $2,451
2024-12-31 $2,531
2024-09-30 $2,525
2024-06-30 $2,541
2024-03-31 $2,196
2023-12-31 $2,200
2023-09-30 $2,011
2023-06-30 $1,962
2023-03-31 $1,935
2022-12-31 $1,878
2022-09-30 $1,865
2022-06-30 $1,821
2022-03-31 $1,860
2021-12-31 $1,831
2021-09-30 $1,801
2021-06-30 $1,794
2021-03-31 $1,820
2020-12-31 $1,318
2020-09-30 $1,418
2020-06-30 $1,433
2020-03-31 $1,267
2019-12-31 $1,238
2019-09-30 $1,191
2019-06-30 $1,260
2019-03-31 $1,275
2018-12-31 $1,228
2018-09-30 $1,266
2018-06-30 $1,241
2018-03-31 $1,237
2017-12-31 $1,312
2017-09-30 $1,271
2017-06-30 $1,251
2017-03-31 $1,239
2016-12-31 $1,306
2016-09-30 $1,335
2016-06-30 $1,317
2016-03-31 $1,319
2015-12-31 $1,336
2015-09-30 $1,419
2015-06-30 $1,427
2015-03-31 $1,485
2014-12-31 $1,474
2014-09-30 $1,475
2014-06-30 $1,477
2014-03-31 $1,514
2013-12-31 $1,488
2013-09-30 $1,484
2013-06-30 $1,480
2013-03-31 $1,462
2012-12-31 $1,474
2012-09-30 $1,455
2012-06-30 $928
2012-03-31 $911
2011-12-31 $848
2011-09-30 $824
2011-06-30 $853
2011-03-31 $833
2010-12-31 $783
2010-09-30 $738
2010-06-30 $698
2010-03-31 $761
2009-12-31 $702
2009-09-30 $714
2009-06-30 $692
2009-03-31 $650
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.367B $1.361B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $235.957B 28.37
Boston Scientific (BSX) United States $147.560B 36.94
Stryker (SYK) United States $144.011B 30.11
EssilorLuxottica (ESLOY) France $127.141B 0.00
Medtronic (MDT) Ireland $111.928B 15.87
Lonza Group Ag (LZAGY) Switzerland $50.371B 0.00
Haleon (HLN) United Kingdom $48.926B 27.87
ResMed (RMD) United States $36.560B 27.46
Agilent Technologies (A) United States $33.258B 21.68
GE HealthCare Technologies (GEHC) United States $33.082B 15.71
Terumo (TRUMY) Japan $26.680B 34.65
Insulet (PODD) United States $21.438B 84.15
Koninklijke Philips (PHG) Netherlands $21.384B 15.37
Zimmer Biomet Holdings (ZBH) United States $18.060B 11.60
Baxter (BAX) United States $15.713B 11.73
Smith & Nephew SNATS (SNN) United Kingdom $12.872B 0.00
Demant (WILYY) Denmark $9.377B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Bio-Rad Laboratories (BIO) United States $6.175B 21.49
Lantheus Holdings (LNTH) United States $5.385B 13.58
Prestige Consumer Healthcare (PBH) United States $4.149B 18.54
Perrigo (PRGO) Ireland $3.664B 9.29
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.250B 23.96
Envista Holdings (NVST) United States $3.127B 25.99
QuidelOrtho (QDEL) United States $1.954B 13.44
LeMaitre Vascular (LMAT) United States $1.833B 40.97
AtriCure (ATRC) United States $1.565B 0.00
Acuren (TIC) United States $1.357B 0.00
Neogen (NEOG) United States $1.200B 15.36
AdaptHealth (AHCO) United States $1.161B 11.78
Green Thumb Industries (GTBIF) United States $1.048B 23.58
BioLife Solutions (BLFS) United States $1.046B 0.00
Phibro Animal Health (PAHC) United States $0.970B 12.40
Kestra Medical Technologies (KMTS) United States $0.904B 0.00
InMode (INMD) Israel $0.844B 8.51
Evolus (EOLS) United States $0.640B 0.00
CeriBell (CBLL) United States $0.624B 0.00
Owens & Minor (OMI) United States $0.602B 4.99
Maravai LifeSciences Holdings (MRVI) United States $0.542B 0.00
Capricor Therapeutics (CAPR) United States $0.538B 0.00
Curaleaf Holdings (CURLF) Canada $0.524B 0.00
Valneva SE (VALN) France $0.510B 0.00
Surmodics (SRDX) United States $0.417B 0.00
Tilray Brands (TLRY) Canada $0.407B 0.00
SNDL (SNDL) Canada $0.339B 0.00
VAREX IMAGING (VREX) United States $0.337B 12.41
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Aurora Cannabis (ACB) Canada $0.329B 58.50
Canopy Growth (CGC) Canada $0.272B 0.00
Viemed Healthcare (VMD) United States $0.263B 22.17
Sanara MedTech (SMTI) United States $0.256B 0.00
Sanuwave Health (SNWV) United States $0.254B 0.00
ZimVie (ZIMV) United States $0.253B 11.52
Cerus (CERS) United States $0.252B 0.00
Cresco Labs (CRLBF) United States $0.245B 0.00
Quanterix (QTRX) United States $0.235B 0.00
OraSure Technologies (OSUR) United States $0.221B 0.00
Biote (BTMD) United States $0.207B 5.82
Brainsway (BWAY) Israel $0.206B 54.50
Omeros (OMER) United States $0.199B 0.00
TriSalus Life Sciences (TLSI) United States $0.196B 0.00
Organigram Global (OGI) Canada $0.187B 0.00
High Tide (HITI) Canada $0.185B 0.00
Utah Medical Products (UTMD) United States $0.179B 14.59
Verano Holdings (VRNOF) United States $0.174B 0.00
Exagen (XGN) United States $0.152B 0.00
Vireo Growth (VREOF) United States $0.140B 0.00
FitLife Brands (FTLF) United States $0.131B 16.18
Jin Medical (ZJYL) China $0.107B 0.00
MacroGenics (MGNX) United States $0.096B 0.00
Fonar (FONR) United States $0.090B 11.64
Veru (VERU) United States $0.090B 0.00
Quipt Home Medical (QIPT) United States $0.087B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Agape ATP (ATPC) $0.084B 0.00
TerrAscend (TSNDF) Canada $0.075B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
InterCure (INCR) Israel $0.068B 0.00
Apyx Medical (APYX) United States $0.066B 0.00
Zynex (ZYXI) United States $0.064B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Modular Medical (MODD) United States $0.042B 0.00
Nephros (NEPH) United States $0.041B 55.29
United-Guardian (UG) United States $0.037B 12.90
Rockwell Medical (RMTI) United States $0.032B 0.00
Cellectar Biosciences (CLRB) United States $0.019B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
Safety Shot (SHOT) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.017B 0.00
INLIF (INLF) $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
Senestech (SNES) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00